The Manufacturers Life Insurance Company Sells 507,924 Shares of UnitedHealth Group Incorporated $UNH

The Manufacturers Life Insurance Company lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 19.7% during the second quarter, HoldingsChannel reports. The institutional investor owned 2,071,359 shares of the healthcare conglomerate’s stock after selling 507,924 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in UnitedHealth Group were worth $860,919,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the business. Sarver Vrooman Wealth Advisors purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $25,000. Nalls Sherbakoff Group LLC bought a new position in shares of UnitedHealth Group in the 4th quarter worth $27,000. Lifetime Wealth Management P.C. bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $29,000. Wilkerson Advisory Group LLC bought a new position in UnitedHealth Group in the fourth quarter valued at $30,000. Finally, Aberdeen Wealth Management LLC purchased a new stake in UnitedHealth Group during the second quarter valued at about $31,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Down 1.4%

NYSE UNH opened at $387.69 on Friday. The stock has a market cap of $347.98 billion, a P/E ratio of 24.95, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61. UnitedHealth Group Incorporated has a fifty-two week low of $255.96 and a fifty-two week high of $461.62. The stock has a 50 day simple moving average of $409.50 and a two-hundred day simple moving average of $367.63. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.78.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. The company had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm’s revenue for the quarter was up .4% on a year-over-year basis. During the same quarter in the prior year, the company earned $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be given a dividend of $2.32 per share. The ex-dividend date is Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. UnitedHealth Group’s payout ratio is currently 59.72%.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: TPG investment could support Optum Health’s turnaround. UnitedHealth is selling a partial stake in certain Florida WellMed primary-care operations to TPG while retaining an interest. The deal brings local investment and strategic support that management expects could accelerate growth, improve clinic performance and strengthen profitability. UnitedHealth Reshapes Florida WellMed Operations With TPG Deal
• Positive Sentiment: Management continues to point to areas of operational progress. Commentary at the Wells Fargo healthcare conference reportedly indicated stronger Medicare Advantage performance and a steadier Medicaid outlook. Analysts remain constructive in some cases, with the median recent price target above the current trading range. UnitedHealth Wells Fargo Conference Transcript
• Positive Sentiment: Reduced prior-authorization requirements may improve efficiency. UnitedHealthcare plans to remove authorization requirements for additional services beginning October 1, targeting 30% of healthcare services by the end of 2026. The initiative could lower administrative costs and improve relationships with patients and providers, although its financial benefit remains uncertain. UnitedHealth is Removing More Prior Authorizations
• Neutral Sentiment: UnitedHealth is investing heavily in artificial intelligence. Nearly $1.5 billion is being directed toward AI and Optum Insight software, with the goal of increasing efficiency and creating new growth opportunities. The strategy could support longer-term expansion, but it also requires substantial investment before results are visible. UnitedHealth’s AI Strategy
• Negative Sentiment: The WellMed transaction is raising concerns about Optum Health. Investors may view bringing in TPG as evidence that the Florida clinic business needs outside capital or operational assistance. The clinics were among the operations associated with UnitedHealth’s recent profit setbacks, making the deal a reminder that the Optum turnaround remains incomplete. UnitedHealth Sells WellMed to TPG
• Negative Sentiment: Medical-cost and margin concerns continue to weigh on managed-care stocks. Comments from CVS Health about persistently high medical-cost trends hurt sentiment across the sector. UnitedHealth also faces pressure in commercial insurance, while its valuation remains elevated relative to some peers despite slower revenue growth. CVS Still Sees High-Trend Cost Growth

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. TD Cowen increased their target price on shares of UnitedHealth Group from $337.00 to $430.00 and gave the company a “hold” rating in a report on Tuesday, July 14th. Royal Bank Of Canada raised their price objective on UnitedHealth Group from $463.00 to $478.00 and gave the company an “outperform” rating in a research note on Friday, July 17th. KeyCorp boosted their target price on UnitedHealth Group from $400.00 to $475.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. Sanford C. Bernstein restated an “outperform” rating on shares of UnitedHealth Group in a research report on Wednesday, September 2nd. Finally, HSBC boosted their price objective on UnitedHealth Group from $300.00 to $380.00 and gave the company a “hold” rating in a research report on Monday, July 6th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $456.56.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.19% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified health care and well-being company headquartered in Minnetonka, Minnesota. Its operations are organized primarily through two businesses: UnitedHealthcare, which provides health benefit plans and services, and Optum, which delivers health care services, technology, pharmacy care and data-driven solutions.

UnitedHealthcare serves individuals, employers, government programs and other organizations through products that include employer-sponsored health plans, individual and family coverage, Medicare and Medicaid plans, dental and vision benefits, and related administrative services.